Zyden Gentec incorporates WOS in Hong Kong

12 Nov 2012 Evaluate

Zyden Gentec has incorporated its 100% wholly owned subsidiary (WOS) in Hong Kong. The board at its meeting held on November 09, 2012 has transacted and took the note of the same.

Zyden Gentec’s principal activity is to manufacture pharmaceutical products and to provide consultancy services. The company operates in two segments namely Manufacturing & Allied Activities and Financial, Investment & Allied Activities. The products of the company include specialized chemicals, bulk drugs, compounds and intermediates.

Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 924.35
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×